McKesson to Buy Precision Medicine Group in About $2.25 Billion Deal

McKesson opens wallet for $2.25 billion amid reorganization, layoffs

Dallas-Fort Worth's largest public company is buying a Bethesda, Maryland-based research and development services company for $2.25 billion. Read on to learn more about the deal.

McKesson to buy Precision Medicine Group in about $2.25 billion deal

Aug 25 (Reuters) - U.S. drug distributor McKesson said ​on Tuesday ‌it would buy clinical research and biopharma commercialization services ‌provider ​Precision ⁠Medicine Group ⁠in a deal valued at about $2.25 billion. The acquisition will ​expand McKe...

McKesson to acquire Precision Medicine Group

IRVING, Texas — McKesson Corp. has signed a definitive agreement to acquire Precision Medicine Group, a global provider of clinical research and biopharma commercialization services.McKesson will acquire Precision Medicine Group for approximately $2.25 billion. Following completion of the transaction, Precision Medicine Group will report within McKesson’s Oncology & Multispecialty segment. The transaction is subject to customary closing conditio…

McKesson Signs Agreement to Acquire Precision Medicine Group, LLC

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global provider of clinical research and biopharma commercialization services. McKesson will acquire Precision Medicine Group for approximately $2.25 billion. Following completion of the transaction, Precision Medicine Group will report within McKesson’s On…